
Syngenta agreed to settle lawsuits brought by U.S. corn farmers who claimed it negligently commercialized the Viptera GMO corn seed before China approved it. The article notes that Chinese authorities had rejected millions of tonnes of U.S. corn imports before approving Viptera in December 2014.
The settlement removes litigation risk around GMO corn commercialization but has little direct effect on prices. It is a reminder that biotech approval gaps can disrupt corn export flows to China.
Setelah 480 peristiwa perdagangan netral sebelumnya, Jagung bergerak median +0,2% selama 5 sesi (54% lebih tinggi; separuh tengah -1,1% sampai +1,6%), dan +0,7% selama 20 sesi.
Pergerakan benchmark setiap komoditas dari penutupan terakhir sebelum peristiwa. Pembacaan historis menggabungkan peristiwa serupa di masa lalu; itu menggambarkan apa yang terjadi, bukan apa yang akan terjadi. Bukan nasihat investasi.